Calcaneal Ultrasound Shows Promise in Fracture Risk Assessment for Type 2 Diabetes Patients: Study
A recent study published in Clinical Endocrinology explores the usefulness of calcaneal quantitative ultrasound (QUS) as a tool for long-term fracture risk assessment in individuals with diabetic osteopathy, particularly those with type 2 diabetes mellitus (T2DM). While traditional methods like bone densitometry and commonly used fracture risk algorithms often lack reliability in diabetic patients, QUS offers a promising, non-invasive and low-cost alternative that has already proven effective in primary osteoporosis.
The study aimed to determine whether calcaneal QUS could provide accurate estimates of fragility fracture risk over a decade. Researchers reviewed records from 300 patients with either type 1 (T1DM) or type 2 diabetes who underwent calcaneal QUS testing in 2013. This evaluation included measurements of broadband ultrasound attenuation (BUA), speed of sound (SOS), and stiffness index (SI), along with patient histories of clinical fragility fractures and diabetes-related characteristics.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.